AnimalBiome Completes Seed Funding Round
AnimalBiome recently completed a seed funding round totaling $1.5 million, bringing the company’s total raised to date to $2.25 million, according to officials. The Oakland, Calif.-based company provides personalized recommendations for nutrition and supplements based on genetic sequencing of bacteria in the microbiome of companion animals.
In related news, Carlton Osborne, JD, will be taking over as AnimalBiome’s new CEO. Carlton replaces Holly Ganz, Ph.D., who will be moving into the chief science officer position.
“With the support of our investors, we’re accelerating developments of our products and will continue to provide pet parents with revolutionary science to boost pet health, happiness and longevity by improving their microbiomes,” Dr. Ganz said. “We’re very excited to see what the future holds for AnimalBiome, especially with Carlton as our new CEO. We feel confident his leadership skills and business expertise will continue to follow our mission and achieve our company goals. And this will allow me to focus on developing better ways to use the microbiome to monitor and improve the health of dogs and cats.”
Osborne brings more than 15 years of start-up and business development experience with focus on rapid revenue growth and customer experience, officials said.
“I was an early adviser and investor in AnimalBiome because it has a revolutionary approach to helping the millions of dogs and cats that suffer from digestive disorders that often cause diarrhea, vomiting and constipation,” Osborne said. “AnimalBiome is uniquely positioned to harness the potential of the microbiome to deliver personalized nutrition products and services for dogs and cats.”